Medicines, 2014
Shortlist up to four to read them side by side.
1,562 medicine recalls FDA’s Enforcement Report published in 2014, newest first; 18,075 in all since 2012.
FDA’s medicine recalls, as its Enforcement Report classifies them, from June 2012. Lists of FDA’s records can’t be saved for alerts: openFDA asks that its data not be used to alert the public (openFDA); FDA’s own emails do that. Copied Nov 5, 2026.
1,562of 1,562 medicine recallsshown with your filters
The list
- Medicine recall Ascorbic Acid 500 mg/mL Sterile Injection, 50mL Multi-dose Vial Non-Sterility: Failing sterility results were obtained from the recalling firm’s contract testing facility indicating that the products may not be sterile. FDA Class I, its most serious class Class IFDA’s class (needs attention)Dec 31, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedDec 31, 2014ClassClass IStatusTerminatedWhereFlorida, New Jersey, New York and Puerto Rico
- Medicine recall Glutathione 100mg/mL Sterile Injection, 30 mL Multi Dose Vial Non-Sterility: Failing sterility results were obtained from the recalling firm’s contract testing facility indicating that the products may not be sterile. FDA Class I, its most serious class Class IFDA’s class (needs attention)Dec 31, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedDec 31, 2014ClassClass IStatusTerminatedWhereFlorida, New Jersey, New York and Puerto Rico
- Medicine recall Magnesium Chloride 20% Non-Sterility: Failing sterility results were obtained from the recalling firm’s contract testing facility indicating that the products may not be sterile. FDA Class I, its most serious class Class IFDA’s class (needs attention)Dec 31, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedDec 31, 2014ClassClass IStatusTerminatedWhereFlorida, New Jersey, New York and Puerto Rico
- Medicine recall Tropi/Cyclo/Phenyl/Tobra/Flurb Non-Sterility: Failing sterility results were obtained from the recalling firm’s contract testing facility indicating that the products may not be sterile. FDA Class I, its most serious class Class IFDA’s class (needs attention)Dec 31, 2014in FDA’s Enforcement Report4 statesnamed in where it went PublishedDec 31, 2014ClassClass IStatusTerminatedWhereFlorida, New Jersey, New York and Puerto Rico
- Medicine recall Hydroxyprogesterone Caproate, 250 mg per mL, 5 mL vial, Rx, Vann Healthcare Pharmacy, 1220 N Race Street,… Lack of Assurance of Sterility: A recent FDA inspection of Vann Healthcare Services facility revealed deficiencies that raise concerns about the pharmacy’s… Class IIFDA’s classDec 31, 2014in FDA’s Enforcement ReportKentuckythe one state its words name PublishedDec 31, 2014ClassClass IIStatusTerminatedWhereKentucky
- Medicine recall Epinephrine 1:1000, 0.15 mL Lack of Assurance of Sterility: A recent FDA inspection of Vann Healthcare Services facility revealed deficiencies that raise concerns about the pharmacy’s… Class IIFDA’s classDec 31, 2014in FDA’s Enforcement ReportKentuckythe one state its words name PublishedDec 31, 2014ClassClass IIStatusTerminatedWhereKentucky
- Medicine recall Lidocaine 4% Syr (PF) Rx, 1 mL Lack of Assurance of Sterility: A recent FDA inspection of Vann Healthcare Services facility revealed deficiencies that raise concerns about the pharmacy’s… Class IIFDA’s classDec 31, 2014in FDA’s Enforcement ReportKentuckythe one state its words name PublishedDec 31, 2014ClassClass IIStatusTerminatedWhereKentucky
- Medicine recall Tri-mix #4 (Papaverine 30 mg, Phentolamine 1 mg, Prostaglandin-1 10 mcg/mL) Lack of Assurance of Sterility: A recent FDA inspection of Vann Healthcare Services facility revealed deficiencies that raise concerns about the pharmacy’s… Class IIFDA’s classDec 31, 2014in FDA’s Enforcement ReportKentuckythe one state its words name PublishedDec 31, 2014ClassClass IIStatusTerminatedWhereKentucky
- Medicine recall Dacarbazine, Injection, USP, 200mg, vials Discoloration: Reconstituted solution may appear pink instead of colorless to pale yellow when stored per the labeled conditions. Class IIIFDA’s classDec 31, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedDec 31, 2014ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall MAYHEM capsules, Proprietary Blend 525 mg, Dietary Supplement, 60-count bottles, Chaotic-Labz Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared dexamethasone and cyproheptadine which are FDA approved drugs… Class IIFDA’s classDec 31, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedDec 31, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall New Life Nutritional SUPER FAT BURNER, bottle contains 30 CAPSULES, product is Marketed without an approved NDA/ANDA - New Life Nutritional Center is recalling SUPER FAT BURNER, MAXI GOLD WEIGHT LOSS PILL and Esmeralda products marketed… FDA Class I, its most serious class Class IFDA’s class (needs attention)Dec 31, 2014in FDA’s Enforcement Report6 statesnamed in where it went PublishedDec 31, 2014ClassClass IStatusTerminatedWhereLouisiana, Massachusetts, New Jersey, New York, Texas and Virginia
- Medicine recall MAXI GOLD WEIGHT LOSS PILL, bottle contains 30 CAPSULES, product is Marketed without an approved NDA/ANDA - New Life Nutritional Center is recalling SUPER FAT BURNER, MAXI GOLD WEIGHT LOSS PILL and Esmeralda products marketed… FDA Class I, its most serious class Class IFDA’s class (needs attention)Dec 31, 2014in FDA’s Enforcement Report6 statesnamed in where it went PublishedDec 31, 2014ClassClass IStatusTerminatedWhereLouisiana, Massachusetts, New Jersey, New York, Texas and Virginia
- Medicine recall Esmeralda, bottle contains 30 Softgels, product is Marketed without an approved NDA/ANDA - New Life Nutritional Center is recalling SUPER FAT BURNER, MAXI GOLD WEIGHT LOSS PILL and Esmeralda products marketed… FDA Class I, its most serious class Class IFDA’s class (needs attention)Dec 31, 2014in FDA’s Enforcement Report6 statesnamed in where it went PublishedDec 31, 2014ClassClass IStatusTerminatedWhereLouisiana, Massachusetts, New Jersey, New York, Texas and Virginia
- Medicine recall sulfur8(R) medicated anti-dandruff conditioner, dandruff treatment for Braids, spray, Active Ingredient:… Failed pH specification: Product pH test value of 5.72 failed to meet its product specification of 6.0 to 7.5. Class IIIFDA’s classDec 31, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedDec 31, 2014ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Walgreens ASPIRIN FREE TENSION HEADACHE, Pain Reliever/Pain Reliever Aid, Acetaminophen & Caffeine, 100… Incorrect/Undeclared Excipients: The firm recalled specific lots of Walgreens brand Aspirin Free Tension Headache Caplets due to the presence of sucralose,… Class IIFDA’s classDec 31, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedDec 31, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Eye Drops (Tetrahydrozoline HCl 0.05%), 0.5 FL OZ CGMP Deviations: Active Pharmaceutical Ingredient (API) used for manufacture was stored in a non-GMP compliant warehouse at S.I.M.S., Italy. Class IIIFDA’s classDec 31, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedDec 31, 2014ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Eye Drops A.C. (Tetrahydrozoline HCl 0.05%, Zinc sulfate 0.25%), 0.5 FL OZ CGMP Deviations: Active Pharmaceutical Ingredient (API) used for manufacture was stored in a non-GMP compliant warehouse at S.I.M.S., Italy. Class IIIFDA’s classDec 31, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedDec 31, 2014ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Eye Drops Industrial Strength (Polyethylene glycol 400 1%, Tetrahydrozoline HCl 0.05%), 0.5 FL OZ CGMP Deviations: Active Pharmaceutical Ingredient (API) used for manufacture was stored in a non-GMP compliant warehouse at S.I.M.S., Italy. Class IIIFDA’s classDec 31, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedDec 31, 2014ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Eye Drops Advanced Relief (Dextran 70 0.1%, Polyethylene glycol 400 1%, Povidone 1%, Tetrahydrozoline HCl… CGMP Deviations: Active Pharmaceutical Ingredient (API) used for manufacture was stored in a non-GMP compliant warehouse at S.I.M.S., Italy. Class IIIFDA’s classDec 31, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedDec 31, 2014ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall HEPARIN SODIUM, 1000 USP Heparin Units/500 mL Presence of Particulate Matter: A particulate, confirmed as human hair, was found sealed between the tube and film at the round seal of the unused… FDA Class I, its most serious class Class IFDA’s class (needs attention)Dec 31, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedDec 31, 2014ClassClass IStatusTerminatedWhereNationwide
- Medicine recall Benzonatate Capsules, USP, 100 mg Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules. Class IIFDA’s classDec 31, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedDec 31, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Alprazolam tablets, USP, CIV, 0.25 mg Subpotent Drug Class IIFDA’s classDec 31, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedDec 31, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Benzonatate Capsules, USP, 200 mg, 100-count bottles Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules. Class IIFDA’s classDec 24, 2014in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedDec 24, 2014ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Mercaptopurine Tablets, USP, 50 mg, 30 Tablets Failed USP Dissolution Test Requirements: This sub-recall is in response to Prometheus Laboratories Inc. Class IIFDA’s classDec 24, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedDec 24, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Clinimix E 4.25/10 sulfite-free Lack of Assurance of Sterility; leaks were observed from the bag seam and port seal Class IIFDA’s classDec 24, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedDec 24, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall BELVIQ¿ (Lorcaserin HCl) Tablets, 10 mg, 60-count bottle Labeling:Missing Label: Bottles may not have a product label, or have a label with missing or illegible lot number and/or expiry date. Class IIIFDA’s classDec 24, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedDec 24, 2014ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Meropenem I.V. 1 g is supplied Defective Container: Glass vials may crack due to low (thin) out of specification vial wall thickness which may lead to contamination and lack of assurance of… Class IIFDA’s classDec 24, 2014in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedDec 24, 2014ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Wockhardt Metoprolol Succinate, Extended-Release Tablets USP, 50 mg, a)100-count HDPE bottle (NDC… Failed Dissolution Specifications: Product was out of specification (OOS) at the 12 month long term stability testing point. Class IIIFDA’s classDec 24, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedDec 24, 2014ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall GENTAMICIN INJECTION, USP, equivalent to 40 mg/mL Defective Container: Vials may be missing stoppers. Class IIFDA’s classDec 17, 2014in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedDec 17, 2014ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Fluoxetine Capsules USP, 20 mg, 100 count bottle Labeling: Illegible Label: Sandoz Inc. Class IIIFDA’s classDec 17, 2014in FDA’s Enforcement ReportArizonathe one state its words name PublishedDec 17, 2014ClassClass IIIStatusTerminatedWhereArizona
- Medicine recall Tikosyn (dofetilide) 125 mcg Failed Tablet/Capsule Specifications: Product being recalled due to the potential presence of cracked or broken capsules. Class IIFDA’s classDec 17, 2014in FDA’s Enforcement ReportNot namedno state, in where it went PublishedDec 17, 2014ClassClass IIStatusTerminatedWhereNo state named
- Medicine recall Famotidine Injection 20 mg Presence of Particulate Matter: Baxter Healthcare Corporation has received a complaint reporting the presence of particulate matter identified as… Class IIFDA’s classDec 17, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedDec 17, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Fentanyl Citrate Injection, USP, 2500 mcg Fentanyl/50 mL, 50 mL Single-dose Flip top Vial (C-II) Lack of Assurance of Sterility; improperly crimped fliptop vials Class IIFDA’s classDec 17, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedDec 17, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall MIDAZOLAM HYDROCHLORIDE INJECTION, 5 mg/1 mL, C-IV, For IM or IV Use, 2 mL Vials Lack of Assurance of Sterility: Glass vials may have finish fractures and glass particles. Class IIFDA’s classDec 17, 2014in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedDec 17, 2014ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall ONDANSETRON INJECTION, USP, 4 mg/ 2 mL Lack of Assurance of Sterility: Glass vials may have finish fractures and glass particles. Class IIFDA’s classDec 17, 2014in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedDec 17, 2014ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall CYANOCOBALAMIN INJECTION, USP, 1000 mcg/mL, For IM or IV Use, Multiple Dose 2 mL Vials Lack of Assurance of Sterility: Glass vials may have finish fractures and glass particles. Class IIFDA’s classDec 17, 2014in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedDec 17, 2014ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Scrub Care Chlorhexidine Gluconate Solution, 4% Surgical Hand Scrub, OTC, CareFusion, Vernon Hills, IL 60061 Does Not Meet Monograph: Chlorhexidine Gluconate Surgical Scrub Brush is being recalled due to higher concentrations of available chlorhexidine gluconate. Class IIIFDA’s classDec 17, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedDec 17, 2014ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall candesartan cilexetil, tablets, 16 mg, 90-count bottles Failed Impurities/Degradation Specifications: An Out of Specification (OOS) result was generated for the 18 month stability time point for ketone cilexetil… Class IIIFDA’s classDec 10, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedDec 10, 2014ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall BENZONATATE Capsules, USP, 200 mg, 100 Capsule Bottles Presence of Foreign Capsules/Tablets: Benzonatate 100 mg co-mingled with benzonatate 200 mg capsules. Class IIIFDA’s classDec 10, 2014in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedDec 10, 2014ClassClass IIIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Potassium Chloride Injection, 10mEq per 100mL, 100 mL Sterile single dose container bags Labeling: Label Error On Declared Strength: Bags of Potassium Chloride 10 mEq per 100 mL were incorrectly overpouched with wraps labeled as Potassium Chloride… Class IIFDA’s classDec 3, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedDec 3, 2014ClassClass IIStatusTerminatedWhereNationwide
- Medicine recall Amlodipine Besylate Tablets, USP 10 mg Discoloration: Brown spots were noted embedded in Amlodipine Besylate Tablets, 10 mg, Lot # MP4344. Class IIIFDA’s classDec 3, 2014in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedDec 3, 2014ClassClass IIIStatusTerminatedWhereNationwide
- Medicine recall Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 75 mg/0.2 mg, 60-count bottle Failed Tablet/Capsule Specifications: Presence of split or broken tablets. Class IIFDA’s classDec 3, 2014in FDA’s Enforcement ReportNationwideFDA’s word, and 1 state named PublishedDec 3, 2014ClassClass IIStatusTerminatedWhereNationwide, and Puerto Rico named
- Medicine recall Testosterone CYP-250/PROP-20 mg, 10 Ml Syringe, Compounded Rx, Perry Drug Compounding Pharmacy, Overland… Lack of sterility assurance;All lots of sterile products compounded by the pharmacy that are within expiry were recalled due to concerns associated with… Class IIFDA’s classDec 3, 2014in FDA’s Enforcement Report2 statesnamed in where it went PublishedDec 3, 2014ClassClass IIStatusTerminatedWhereKansas and Missouri
- Medicine recall Methyl B12 25 mg/mL Inj., 10 Syringes, Compounded Rx, Perry Drug Compounding Pharmacy, Overland Park, KS Lack of sterility assurance;All lots of sterile products compounded by the pharmacy that are within expiry were recalled due to concerns associated with… Class IIFDA’s classDec 3, 2014in FDA’s Enforcement Report2 statesnamed in where it went PublishedDec 3, 2014ClassClass IIStatusTerminatedWhereKansas and Missouri
- Medicine recall Tri-Mix (PGE-10MCG/PAP-30MG/PT 5Ml vials, Compounded Rx, Perry Drug Compounding Pharmacy, Overland Park, KS Lack of sterility assurance;All lots of sterile products compounded by the pharmacy that are within expiry were recalled due to concerns associated with… Class IIFDA’s classDec 3, 2014in FDA’s Enforcement Report2 statesnamed in where it went PublishedDec 3, 2014ClassClass IIStatusTerminatedWhereKansas and Missouri
- Medicine recall Leuprolide 50 mcg/0.1 mL Micro Lupron Kit, 5Ml, Compounded Rx, Perry Drug Compounding Pharmacy, Overland… Lack of sterility assurance;All lots of sterile products compounded by the pharmacy that are within expiry were recalled due to concerns associated with… Class IIFDA’s classDec 3, 2014in FDA’s Enforcement Report2 statesnamed in where it went PublishedDec 3, 2014ClassClass IIStatusTerminatedWhereKansas and Missouri
- Medicine recall Phenylephrine HCl Lack of sterility assurance;All lots of sterile products compounded by the pharmacy that are within expiry were recalled due to concerns associated with… Class IIFDA’s classDec 3, 2014in FDA’s Enforcement Report2 statesnamed in where it went PublishedDec 3, 2014ClassClass IIStatusTerminatedWhereKansas and Missouri
- Medicine recall Testosterone Cyp 200 mg/mL Sesame Inj., 4Ml Syringes, Compounded Rx, Perry Drug Compounding Pharmacy,… Lack of sterility assurance;All lots of sterile products compounded by the pharmacy that are within expiry were recalled due to concerns associated with… Class IIFDA’s classDec 3, 2014in FDA’s Enforcement Report2 statesnamed in where it went PublishedDec 3, 2014ClassClass IIStatusTerminatedWhereKansas and Missouri
Nothing matches all of these.
Remove a filter to see more. Each one is a fact FDA’s record publishes, so a recall can be left out because its record is silent on it.
FDA, Drug recall enforcement reports. Released Nov 3, 2026. Updated weekly.
Recalls of food, medicines, medical devices, pet food and animal drugs are from the U.S. Food and Drug Administration (FDA). FDA does not endorse Hearth Record. openFDA: “Do not rely on openFDA to make decisions regarding medical care.”
Your shortlist0 of 4
Add one more to compare.